Catalyst Wire Dossier Catalyst Wire Dossier

Enolen

enzalutamide · Alessa Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Enolen, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Enzalutamide Implants (Enolen) in Patients With Prostate Cancer [Phase 1]

See pricing